Rong Tao, MD
Fudan University · Shanghai Cancer Center · Fudan Cancer Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Rong Tao, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:42 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07768943 · GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell LymphomaFudan University · not yet recruiting · Natural Killer/T-cell Lymphoma · study chair
- Ph3NCT07678229 · BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCLRong Tao · recruiting · Extranodal NK/T-cell Lymphoma · study chair
- Ph2NCT07507318 · Chidamide Maintenance for MRD-Positive Double-Expressor DLBCL in First Complete RemissionRong Tao · recruiting · Diffuse Large B-Cell Lymphoma · study chair
- Ph1/Ph2NCT07502768 · Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell LymphomaRong Tao · recruiting · Extranodal NK/T-cell Lymphoma, NK/T-cell Lymphoma, Relapsed or Refractory NK/T-Cell Lymphoma · study chair
- Ph3NCT07300514 · Golidocitinib Versus Placebo as Maintenance Therapy for Peripheral T-Cell LymphomaFudan University · recruiting · Maintenance Treatment of Peripheral T-cell Lymphoma · principal investigator
- N/ANCT07270861 · Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort StudyFudan University · recruiting · Peripheral T-Cell Lymphoma · study chair
- Ph2NCT06519526 · Exploratory Clinical Study of SHR-0302 and SHR-2554 in Patients With Relapsed/Refractory Peripheral T Cell LymphomaFudan University · recruiting · Relapsed/Refractory Peripheral T Cell Lymphoma · principal investigator
- Ph2NCT06517511 · Selinexor in Combination With R-CHOP as the First-line Therapy for TP53-mutated DLBCL Patients (Smart Trial)Sun Yat-sen University · recruiting · Diffuse Large B Cell Lymphoma · principal investigator
- Ph1NCT06517004 · An Open-label, Single-arm Study of JWCAR201 in the Treatment of Relapsed or Refractory Diffuse Large B-cell LymphomaFudan University · recruiting · Diffuse Large B Cell Lymphoma · principal investigator
- Ph1NCT06445803 · CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHLRong Tao · recruiting · Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, B-cell Lymphoma Refractory · principal investigator
- Ph2NCT06314334 · Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell LymphomaFudan University · recruiting · Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · study chair
- N/ANCT05058755 · Tislelizumab Combined Treatment in Refractory Extranodal NK/T-cell LymphomaXinhua Hospital, Shanghai Jiao Tong University School of Medicine · completed · Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · principal investigator
- N/ANCT04366128 · Camrelizumab, Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTLRong Tao · completed · Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · principal investigator
- Ph2NCT04004572 · Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell LymphomaRong Tao · completed · Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · principal investigator
- Ph2NCT03618238 · Anlotinib for Advanced and Refractory Natural Killer /T-cell LymphomaXinhua Hospital, Shanghai Jiao Tong University School of Medicine · completed · Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type · principal investigator
- N/ANCT03079544 · Social Media-based Active Self-report on Incidence and Outcomes of Adverse Events in NK/TCL PatientsRong Tao · completed · Extranodal NK-T-Cell Lymphoma, Nasal Type · study chair
- N/ANCT02764281 · MEDA Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation for Stage IV Natural Killer/T-cell LymphomaXinhua Hospital, Shanghai Jiao Tong University School of Medicine · completed · Extranodal NK-T-Cell Lymphoma, Nasal Type · study chair
- N/ANCT02733458 · GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell LymphomaXinhua Hospital, Shanghai Jiao Tong University School of Medicine · completed · Extranodal NK-T-Cell Lymphoma, Nasal Type · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:42 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.